Bridgewater Associates’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,471
Closed -$252K 700
2024
Q3
$252K Sell
10,471
-5,663
-35% -$129K ﹤0.01% 754
2024
Q2
$321K Sell
16,134
-1,127
-7% -$21.9K ﹤0.01% 810
2024
Q1
$344K Sell
17,261
-15,529
-47% -$300K ﹤0.01% 649
2023
Q4
$735K Sell
32,790
-21,584
-40% -$446K ﹤0.01% 672
2023
Q3
$1.1M Buy
54,374
+4,516
+9% +$102K 0.01% 591
2023
Q2
$1.27M Sell
49,858
-6,381
-11% -$168K 0.01% 543
2023
Q1
$1.67M Buy
56,239
+1,974
+4% +$57.3K 0.01% 488
2022
Q4
$1.47M Sell
54,265
-18,638
-26% -$456K 0.01% 583
2022
Q3
$1.59M Sell
72,903
-1,306
-2% -$34.1K 0.01% 607
2022
Q2
$2.03M Buy
74,209
+6,640
+10% +$191K 0.01% 683
2022
Q1
$2.26M Buy
67,569
+14,618
+28% +$471K 0.01% 655
2021
Q4
$1.84M Buy
52,951
+5,735
+12% +$185K 0.01% 475
2021
Q3
$1.47M Sell
47,216
-2,422
-5% -$82.2K 0.01% 473
2021
Q2
$1.8M Buy
+49,638
New +$2.05M 0.01% 509

Other funds holding AVNS